Hidden patterns: how three chronic diseases often travel together
NCT ID NCT07660757
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed observational study looked at 4500 patients admitted to internal medicine wards with heart failure, COPD, or chronic kidney disease. Researchers aimed to identify which other chronic conditions tend to cluster with these diseases, and how those clusters affect patient outcomes. The goal is to better understand multimorbidity in older adults and improve care strategies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage the combination of chronic diseases that often occur together in older patients.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and the findings may not apply to all patient groups or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
4,500 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
53 Internal Medicine Units, and for each of them the enrollment of approximately 100 consecutively hospitalized adult patients affected by at least one chronic disease among heart failure, COPD and chronic renal failure in the Medicine Units is planned, for a total of at least 1500 subjects per disease group
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients admitted to Internal Medicine with a diagnosis of at least one of the following chronic conditions: * heart failure * COPD * chronic kidney disease * Acceptance of participation in the study by signing the informed consent Exclusion Criteria: * Patients who do not consent to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease (CKD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antonella Valerio
Roma, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- COPD may affect the brain and muscles, not just the lungs
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- New drug RO7830698 put to the test for COPD
- Can better training get doctors to talk about what matters most to dying veterans?